I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Antiphospholipid Syndrome Committee of the Brazilian Societ..:
Gustavo Guimarães Moreira Balbi
;
Marcelo de Souza Pacheco
;
Odirlei Andre Monticielo
...
http://link.springer.com/article/10.1186/s42358-020-00125-9. , 2020
Link:
https://doi.org/10.1186/s42358-020-00125-9
RT Journal T1
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:bb1f08c30d9a412ab85ff55b77e359a6&Exemplar=1&LAN=DE A1 Gustavo Guimarães Moreira Balbi A1 Marcelo de Souza Pacheco A1 Odirlei Andre Monticielo A1 Andreas Funke A1 Adriana Danowski A1 Mittermayer Barreto Santiago A1 Henrique Luiz Staub A1 Jozelia Rêgo A1 Danieli Castro Oliveira de Andrade PB BMC YR 2020 K1 Antiphospholipid syndrome K1 Factor Xa inhibitors K1 Rivaroxaban K1 Apixaban K1 Edoxaban K1 Antithrombins K1 Diseases of the musculoskeletal system K1 RC925-935 K1 Immunologic diseases. Allergy K1 RC581-607 JF http://link.springer.com/article/10.1186/s42358-020-00125-9 LK http://dx.doi.org/https://doi.org/10.1186/s42358-020-00125-9 DO https://doi.org/10.1186/s42358-020-00125-9 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)